The evidence that maternal use of nicotine replacement therapy (NRT) is safe for the fetus is insufficiently robust, although use of the products is likely to be safer than smoking, according to authors of a review.

In their systematic review and meta-analysis, the researchers believe they have, for the first time, brought together all the observational studies on the topic to be assessed alongside the randomised controlled trial (RCT) data.